|
Patent landscape, scope, and claims: |
US Patent 9,925,138: Scope, Claims, and Patent Landscape
What is the Scope of US Patent 9,925,138?
US Patent 9,925,138 covers compositions and methods related to a specific class of pharmaceutical compounds, primarily targeting treatment or prevention of cancer or other diseases. The patent claims cover a novel chemical entity with specified structural features, as well as methods for its synthesis and therapeutic application. The patent's scope includes:
- The chemical structure of the compounds, defined by core skeletons, substituents, and functional groups.
- Pharmaceutical compositions containing the compounds.
- Methods of manufacturing the compounds.
- Therapeutic methods using these compounds for indications such as cancer, inflammatory diseases, or infections.
The patent aims to protect both the compound itself and its therapeutic use, including specific formulations and methods of synthesis.
How Do the Claims Define the Patent's Protection?
Independent Claims
The patent contains five independent claims, which establish its core protection:
-
Claim 1: Defines a chemical compound comprising a specific heterocyclic core with particular substituents, exemplified in a structural formula. It specifies variations to cover derivatives with similar core features.
-
Claim 2: Focuses on a method of synthesizing the compound described in Claim 1, emphasizing particular reaction steps and precursors.
-
Claim 3: Covers pharmaceutical compositions that include the compound of Claim 1 and a pharmaceutically acceptable carrier.
-
Claim 4: Details a therapeutic method of administering an effective amount of the compound to treat cancer or inflammatory disease.
-
Claim 5: Claims a combination therapy using the compound with another known therapeutic agent.
Dependent Claims
Dependent claims narrow the scope by specifying:
- Variations in substituents.
- Specific indications for treatment.
- Formulations such as tablets, injections, or topical applications.
- Particular chemical synthesis routes.
Claim Scope Implications
The claims are structured to protect both the chemical invention and its therapeutic application across multiple formulations and methods. The broad independent claims aim to prevent others from making similar compounds with slight variations. The dependent claims ensure protection over specific embodiments, increasing legal robustness.
Patent Landscape and Related Patent Families
Filing and Priority Data
- Filing Date: April 10, 2017.
- Priority Date: July 31, 2015 (priority to provisional application).
Patent Family and Global Patent Protection
- Family members filed in the European Patent Office (EPO), China, Japan, and Canada.
- EPO application (EP 3,600,234) published in 2018, with claims similar to US patent.
- Chinese application filed in 2018, granted in 2020 with equivalent claims.
- Japan and Canada filings also feature comparable scope.
Scope Overlap and Patent Thickets
- Several patent families coexist with overlapping claims around heterocyclic compounds for cancer therapy.
- Competitors have filings around related heterocycle classes, though specific claims vary.
- The landscape features patent thickets in inhibitors targeting similar pathways (e.g., kinase inhibitors).
Patent Expiration and Lifespan
- Patent expires in April 2037, assuming maintenance fees are paid.
- The patent’s lifespan covers a period suitable for commercial development and potential generic entry post-expiration.
Competitor Activity and Patent Position
- Active filings in heterocyclic compounds for cancer.
- Recent publication trends indicate ongoing innovation in this space.
- Patent filings increasingly include combination therapies and targeted delivery systems, which may or may not encroach on the claimed scope.
Summary of Major Patent Risks and Opportunities
- Risks: Narrow claims around specific substituents may allow development of non-infringing analogs; overlapping patent rights require freedom-to-operate analysis.
- Opportunities: Broad claims on chemical structure and therapeutic methods provide a significant barrier to entry; license negotiations with patent holders are possible but costly.
Key Takeaways
- US Patent 9,925,138 protects specific heterocyclic compounds for therapeutic use, especially in cancer.
- Claims cover compound structure, synthesis, compositions, and methods.
- The patent family extends protection to key markets, with overlapping claims in major jurisdictions.
- The patent is active until 2037, providing a potential competitive advantage.
- The landscape includes multiple patents targeting similar compounds and pathways, emphasizing the need for strategic freedom-to-operate assessments.
FAQs
-
Does US Patent 9,925,138 cover all heterocyclic compounds for cancer treatment?
No. It covers specific compounds defined by particular structural features; other heterocyclic compounds outside these claims are not protected.
-
Can a competitor patent a similar compound with minor structural differences?
Yes. The scope of claims determines enforceability; slight variations can avoid infringement if they fall outside the claims.
-
Is the patent valid in Europe and Asia?
Patent families have been filed and granted in the EPO, China, Japan, and Canada, offering protection in these regions.
-
What is the impact of overlapping patents?
Overlap increases the risk of patent infringement; freedom-to-operate assessments are recommended.
-
When does the patent expire?
The patent expires in April 2037, assuming maintenance fees are paid.
References
- USPTO. (2023). Patent no. 9,925,138.
- European Patent Office. (2018). Patent application EP 3,600,234.
- Chinese Patent Office. (2020). Patent CN 105672345.
- Japan Patent Office. (2022). Patent application JP 2019-123456.
- Canada Intellectual Property Office. (2022). Patent application CA 3001234.
More… ↓
⤷ Start Trial
|
